Case 3. Imatinib mesylate-induced interstitial pneumonitis

Journal of Clinical Oncology

Volumn 21, Issue 16, 2003, Pages 3171-3173

  Rosado, Manuel F ^a   Donna, Elio ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; COTRIMOXAZOLE; ERYTHROPOIETIN; FERROUS SULFATE; HYDROXYUREA; IMATINIB; PREDNISOLONE; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ADULT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; BRONCHOSCOPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOGENETICS; DRUG WITHDRAWAL; DYSPNEA; EOSINOPHILIA; HISTOPATHOLOGY; HUMAN; HYPOXIA; INTERSTITIAL PNEUMONIA; MALE; NAUSEA AND VOMITING; PRIORITY JOURNAL; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; CHEMICALLY INDUCED DISORDER; INTERSTITIAL LUNG DISEASE; MIDDLE AGED; MYELOID LEUKEMIA;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PIPERAZINES; PYRIMIDINES;

EID: 0041912687     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.03.037     Document Type: Article

References (6)

1. Novartis Pharmaceuticals Corporation: Gleevec (imatinib mesylate). East Hanover, NJ, Novartis Pharmaceuticals Corporation, prescribing information, 2002. www.gleevec.com.
2. Savage DG, Antman KH: Drug therapy: Imatinib mesylate - A new oral targeted therapy. N Engl J Med 346:683-693, 2002
3. Druker BJ, Talpaz M, Resta DJ, et al: Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037, 2001
4. Ottman OG, Sawyers CL, Druker B, et al: A phase II study to determine the safety and anti-leukemic effects of STI 571 in adult patients with Philadelphia chromosome positive acute leukemias. Blood 96:828a, 2000 (abstr 3580)
5. Goldsby R, Pulsipher M, Adams R, et al: Unexpected pleural effusions in 3 pediatric patients treated with STI-571. J Pediatr Hematol Oncol 24:694-695, 2002 (letter)
6. Bergeron A, Bergot E, Vilela G, et al: Hypersensitivity pneumonitis related to imatinib mesylate. J Clin Oncol 20:4271-4272, 2002 (letter)